Artículos de revistas sobre el tema "Drug repurposing against COVID-19"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Drug repurposing against COVID-19".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Mohate, Pratiksha y Madhav D. Zade. "REVIEW ON DRUG REPURPOSING DRUG USEFUL AGAINST COVID-19". International Journal of Engineering Applied Sciences and Technology 5, n.º 2 (30 de junio de 2020): 449–55. http://dx.doi.org/10.33564/ijeast.2020.v05i02.074.
Texto completoRodrigues, Liliana, Renata Bento Cunha, Tatiana Vassilevskaia, Miguel Viveiros y Celso Cunha. "Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates". Molecules 27, n.º 9 (23 de abril de 2022): 2723. http://dx.doi.org/10.3390/molecules27092723.
Texto completoKhataniar, Ankita, Upasana Pathak, Sanchaita Rajkhowa y Anupam Nath Jha. "A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19". COVID 2, n.º 2 (26 de enero de 2022): 148–67. http://dx.doi.org/10.3390/covid2020011.
Texto completoPuccetti, Matteo, Claudio Costantini, Maurizio Ricci y Stefano Giovagnoli. "Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics". Pharmaceutics 13, n.º 4 (5 de abril de 2021): 494. http://dx.doi.org/10.3390/pharmaceutics13040494.
Texto completoWahedi, Hussain Mustatab y Deeba Amraiz. "Repurposing of Antiviral Drugs for Covid-19 Therapy". Life and Science 1, supplement (23 de diciembre de 2020): 10. http://dx.doi.org/10.37185/lns.1.1.151.
Texto completoKumari, Priyanka, Bikram Pradhan, Maria Koromina, George P. Patrinos y Kristel Van Steen. "Discovery of new drug indications for COVID-19: A drug repurposing approach". PLOS ONE 17, n.º 5 (24 de mayo de 2022): e0267095. http://dx.doi.org/10.1371/journal.pone.0267095.
Texto completoKumari, Kanchan y Sandip K Mishra. "Artemisinin and its Derivatives as Repurposing Drug against COVID-19". Acta Scientific Cancer Biology 4, n.º 7 (22 de junio de 2020): 21–23. http://dx.doi.org/10.31080/ascb.2020.04.0237.
Texto completoParvathaneni, Vineela y Vivek Gupta. "Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges". Life Sciences 259 (octubre de 2020): 118275. http://dx.doi.org/10.1016/j.lfs.2020.118275.
Texto completoCiliberto, Gennaro y Luca Cardone. "Boosting the arsenal against COVID-19 through computational drug repurposing". Drug Discovery Today 25, n.º 6 (junio de 2020): 946–48. http://dx.doi.org/10.1016/j.drudis.2020.04.005.
Texto completoKolitz, Sarah, Jason Kim, Jenny Zhang, Yoonjeong Cha, Sailaja Battula, Rebecca Kusko, Rajaraman Krishnan, Benjamin Zeskind y Howard Kaufman. "477 Deep learning to drive COVID-19 rapid drug repurposing". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (noviembre de 2020): A509. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0477.
Texto completoSonkar, Charu, Pawan Kumar Doharey, Anuranjan Singh Rathore, Vishal Singh, Dharmendra Kashyap, Amaresh Kumar Sahoo, Nitish Mittal, Bechan Sharma y Hem Chandra Jha. "Repurposing of gastric cancer drugs against COVID-19". Computers in Biology and Medicine 137 (octubre de 2021): 104826. http://dx.doi.org/10.1016/j.compbiomed.2021.104826.
Texto completoPiplani, Sakshi, Puneet Singh, Nikolai Petrovsky y David A. Winkler. "Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics". International Journal of Molecular Sciences 24, n.º 4 (20 de febrero de 2023): 4192. http://dx.doi.org/10.3390/ijms24044192.
Texto completoHossain, Md Shahadat, Ithmam Hami, Md Sad Salabi Sawrav, Md Fazley Rabbi, Otun Saha, Newaz Mohammed Bahadur y Md Mizanur Rahaman. "Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape". Discoveries 8, n.º 4 (16 de diciembre de 2020): e121. http://dx.doi.org/10.15190/d.2020.18.
Texto completoHan, Namshik, Woochang Hwang, Konstantinos Tzelepis, Patrick Schmerer, Eliza Yankova, Méabh MacMahon, Winnie Lei et al. "Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies". Science Advances 7, n.º 27 (junio de 2021): eabh3032. http://dx.doi.org/10.1126/sciadv.abh3032.
Texto completoBen Moftah, Moayed y Asma Eswayah. "Repurposing of Hydroxyurea Against COVID-19: A Promising Immunomodulatory Role". ASSAY and Drug Development Technologies 20, n.º 1 (1 de enero de 2022): 55–62. http://dx.doi.org/10.1089/adt.2021.090.
Texto completoAherfi, Sarah, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola y Didier Raoult. "Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV". Future Microbiology 16, n.º 17 (noviembre de 2021): 1341–70. http://dx.doi.org/10.2217/fmb-2021-0019.
Texto completoKifle, Zemene Demelash, Akeberegn Gorems Ayele y Engidaw Fentahun Enyew. "Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment". Journal of Environmental and Public Health 2021 (22 de abril de 2021): 1–11. http://dx.doi.org/10.1155/2021/6631721.
Texto completoSingh, Sanjeet y Jayaram R. "A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19". Journal of Pure and Applied Microbiology 14, suppl 1 (28 de mayo de 2020): 765–74. http://dx.doi.org/10.22207/jpam.14.spl1.14.
Texto completoNunes, Paulo, Pedro Henrique de Oliveira Santiago, Cecilia Carolina Pinheiro da Silva y Javier Ellena. "Drug Repurposing of the Antiviral Drug Acyclovir: New Pharmaceutical Salts". Crystals 13, n.º 5 (8 de mayo de 2023): 782. http://dx.doi.org/10.3390/cryst13050782.
Texto completoAnand, Jigisha, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma y Nishant Rai. "Computational guided approach for drug repurposing against SARS-CoV-2". Future Virology 16, n.º 3 (marzo de 2021): 211–43. http://dx.doi.org/10.2217/fvl-2020-0403.
Texto completoLoganathan, Tamizhini, Srimathy Ramachandran, Prakash Shankaran, Devipriya Nagarajan y Suma Mohan S. "Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach". PeerJ 8 (10 de junio de 2020): e9357. http://dx.doi.org/10.7717/peerj.9357.
Texto completoDe Vita, Simona, Maria Giovanna Chini, Gianluigi Lauro y Giuseppe Bifulco. "Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19)". RSC Advances 10, n.º 67 (2020): 40867–75. http://dx.doi.org/10.1039/d0ra09010g.
Texto completoLee, Jong hoon. "Treatment mechanism of immune triad from the repurposing drug against COVID-19". Translational Medicine of Aging 7 (2023): 33–45. http://dx.doi.org/10.1016/j.tma.2023.06.005.
Texto completoInstiaty, I. Gusti Agung Ayu Putu Sri Darmayani, Jefman Efendi Marzuki, Ferina Angelia, William, Angelina Siane, Lela Dwi Sary et al. "Antiviral treatment of COVID-19: a clinical pharmacology narrative review". Medical Journal of Indonesia 29, n.º 3 (18 de julio de 2020): 332–45. http://dx.doi.org/10.13181/mji.rev.204652.
Texto completoChowdhury, Kamrul Hasan, Md Riad Chowdhury, Shafi Mahmud, Abu Montakim Tareq, Nujhat Binte Hanif, Naureen Banu, A. S. M. Ali Reza, Talha Bin Emran y Jesus Simal-Gandara. "Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease". Biology 10, n.º 1 (23 de diciembre de 2020): 2. http://dx.doi.org/10.3390/biology10010002.
Texto completoJang, Woo Dae, Sangeun Jeon, Seungtaek Kim y Sang Yup Lee. "Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay". Proceedings of the National Academy of Sciences 118, n.º 30 (7 de julio de 2021): e2024302118. http://dx.doi.org/10.1073/pnas.2024302118.
Texto completoTaibe, Noha Samir, Maimona A. Kord, Mohamed Ahmed Badawy, Iart Luca Shytaj y Mahmoud M. Elhefnawi. "Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment". Therapeutic Advances in Respiratory Disease 16 (enero de 2022): 175346662211327. http://dx.doi.org/10.1177/17534666221132736.
Texto completoGupta, Rajesh Kumar, Girish R. Apte, Kiran Bharat Lokhande, Satyendra Mishra y Jayanta K. Pal. "Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy". Current Protein & Peptide Science 21, n.º 11 (31 de diciembre de 2020): 1085–96. http://dx.doi.org/10.2174/1389203721666200918153717.
Texto completoBR, Bharath, Hrishikesh Damle, Shiban Ganju y Latha Damle. "In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19". F1000Research 9 (1 de julio de 2020): 663. http://dx.doi.org/10.12688/f1000research.24143.1.
Texto completoMacRaild, Christopher A., Muzaffar-Ur-Rehman Mohammed, Faheem, Sankaranarayanan Murugesan, Ian K. Styles, Amanda L. Peterson, Carl M. J. Kirkpatrick et al. "Systematic Down-Selection of Repurposed Drug Candidates for COVID-19". International Journal of Molecular Sciences 23, n.º 19 (6 de octubre de 2022): 11851. http://dx.doi.org/10.3390/ijms231911851.
Texto completoAlanazi, Khalid Mashay, Mohammad Abul Farah y Yan-Yan Hor. "Multi-Targeted Approaches and Drug Repurposing Reveal Possible SARS-CoV-2 Inhibitors". Vaccines 10, n.º 1 (26 de diciembre de 2021): 24. http://dx.doi.org/10.3390/vaccines10010024.
Texto completoNashte, Aayushka. "Exploring the Potential of Natural Compounds Against Pro-Inflammatory Cytokine Proteins Involved in Worsening COVID-19 and Against COVID-19 Proteins: An in Silico Approach". International Journal of Innovative Technology and Exploring Engineering 11, n.º 9 (30 de agosto de 2022): 74–98. http://dx.doi.org/10.35940/ijitee.g9221.0811922.
Texto completoGupta, Rajaneesh K., Enyinna L. Nwachuku, Benjamin E. Zusman, Ruchira M. Jha y Ava M. Puccio. "Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium". PLOS ONE 16, n.º 9 (28 de septiembre de 2021): e0257784. http://dx.doi.org/10.1371/journal.pone.0257784.
Texto completoHassanzadeganroudsari, Majid, Amir Hossein Ahmadi, Niloufar Rashidi, Md Kamal Hossain, Amanda Habib y Vasso Apostolopoulos. "Computational Chemistry to Repurposing Drugs for the Control of COVID-19". Biologics 1, n.º 2 (15 de julio de 2021): 111–28. http://dx.doi.org/10.3390/biologics1020007.
Texto completoMudatsir, Mudatsir, Amanda Yufika, Firzan Nainu, Andri Frediansyah, Dewi Megawati, Agung Pranata, Wilda Mahdani, Ichsan Ichsan, Kuldeep Dhama y Harapan Harapan. "Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick—A Literature Review". Scientia Pharmaceutica 88, n.º 3 (17 de agosto de 2020): 36. http://dx.doi.org/10.3390/scipharm88030036.
Texto completoMorselli Gysi, Deisy, Ítalo do Valle, Marinka Zitnik, Asher Ameli, Xiao Gan, Onur Varol, Susan Dina Ghiassian et al. "Network medicine framework for identifying drug-repurposing opportunities for COVID-19". Proceedings of the National Academy of Sciences 118, n.º 19 (27 de abril de 2021): e2025581118. http://dx.doi.org/10.1073/pnas.2025581118.
Texto completoAsai, Ayumu, Masamitsu Konno, Miyuki Ozaki, Chihiro Otsuka, Andrea Vecchione, Takahiro Arai, Toru Kitagawa et al. "COVID-19 Drug Discovery Using Intensive Approaches". International Journal of Molecular Sciences 21, n.º 8 (18 de abril de 2020): 2839. http://dx.doi.org/10.3390/ijms21082839.
Texto completoGünther, Sebastian, Patrick Y. A. Reinke, Yaiza Fernández-García, Julia Lieske, Thomas J. Lane, Helen M. Ginn, Faisal H. M. Koua et al. "X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease". Science 372, n.º 6542 (2 de abril de 2021): 642–46. http://dx.doi.org/10.1126/science.abf7945.
Texto completoNarayanan, Anoop, Shay A. Toner y Joyce Jose. "Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases". Biochemical Society Transactions 50, n.º 1 (11 de enero de 2021): 151–65. http://dx.doi.org/10.1042/bst20211180.
Texto completoWang, Bing, Dmitri Svetlov, Dylan Bartikofsky, Christiane E. Wobus y Irina Artsimovitch. "Going Retro, Going Viral: Experiences and Lessons in Drug Discovery from COVID-19". Molecules 27, n.º 12 (14 de junio de 2022): 3815. http://dx.doi.org/10.3390/molecules27123815.
Texto completoCampbell, Courtney M., Avirup Guha, Tamanna Haque, Tomas G. Neilan y Daniel Addison. "Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review". Journal of Clinical Medicine 9, n.º 9 (11 de septiembre de 2020): 2935. http://dx.doi.org/10.3390/jcm9092935.
Texto completoGediz Erturk, Aliye, Arzu Sahin, Ebru Bati Ay, Emel Pelit, Emine Bagdatli, Irem Kulu, Melek Gul et al. "A Multidisciplinary Approach to Coronavirus Disease (COVID-19)". Molecules 26, n.º 12 (9 de junio de 2021): 3526. http://dx.doi.org/10.3390/molecules26123526.
Texto completoTrivedi, Jay, Mahesh Mohan y Siddappa N. Byrareddy. "Drug Repurposing Approaches to Combating Viral Infections". Journal of Clinical Medicine 9, n.º 11 (23 de noviembre de 2020): 3777. http://dx.doi.org/10.3390/jcm9113777.
Texto completoBaby, Krishnaprasad, Swastika Maity, Chetan H. Mehta, Akhil Suresh, Usha Y. Nayak y Yogendra Nayak. "Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19". F1000Research 9 (23 de septiembre de 2020): 1166. http://dx.doi.org/10.12688/f1000research.26359.1.
Texto completoSourimant, Julien, Megha Aggarwal y Richard K. Plemper. "Progress and pitfalls of a year of drug repurposing screens against COVID-19". Current Opinion in Virology 49 (agosto de 2021): 183–93. http://dx.doi.org/10.1016/j.coviro.2021.06.004.
Texto completoRana, Prabha y Vagisha Rawal. "Repurposing of drugs and leading vaccines work against COVID-19". Environment Conservation Journal 23, n.º 1&2 (1 de febrero de 2022): 39–48. http://dx.doi.org/10.36953/ecj.021904-2161.
Texto completoGhanbari, Reza, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, Abolghasem Jouyban y Susan CJ Sumner. "Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients". Future Microbiology 15, n.º 18 (diciembre de 2020): 1747–58. http://dx.doi.org/10.2217/fmb-2020-0120.
Texto completoKiebish, Michael A., Punit Shah, Rangaprasad Sarangarajan, Vivek K. Vishnudas, Stephane Gesta, Poornima K. Tekumalla, Chas Bountra et al. "Bayesian Model Infers Drug Repurposing Candidates for Treatment of COVID-19". Applied Sciences 11, n.º 6 (10 de marzo de 2021): 2466. http://dx.doi.org/10.3390/app11062466.
Texto completoRogosnitzky, Moshe, Esther Berkowitz y Alejandro R. Jadad. "No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19". JMIRx Med 1, n.º 1 (30 de septiembre de 2020): e19583. http://dx.doi.org/10.2196/19583.
Texto completoFiscon, Giulia, Federica Conte, Lorenzo Farina y Paola Paci. "SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19". PLOS Computational Biology 17, n.º 2 (5 de febrero de 2021): e1008686. http://dx.doi.org/10.1371/journal.pcbi.1008686.
Texto completo